Literature DB >> 4283335

Adrenergic supersensitization as a therapeutic tool in glaucoma.

A L Crombie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4283335

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


× No keyword cloud information.
  4 in total

1.  Treatment of chronic simple glaucoma with an adrenaline/guanethidine combination at three different dosages (comparative double-blind study).

Authors:  U Urner-Bloch; J E Aeschlimann; B P Gloor
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

2.  The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment.

Authors:  F J Hoyng; C L Dake
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

3.  Evaluation of a 5% guanethidine and 0.5% adrenaline mixture (Ganda 5.05) and of a 3% guanethidine and 0.5% adrenaline mixture (Ganda 3.05) in the treatment of open-angle glaucoma.

Authors:  J Romano; G Patterson
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

4.  A double-blind short-term trial of guanethidine 3% and adrenaline 0.5% combined in one eye drop.

Authors:  F J Hoyng; C L Dake; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.